CN101432041A - Electromagnetic treatment apparatus for augmenting wound repair and method for using same - Google Patents
Electromagnetic treatment apparatus for augmenting wound repair and method for using same Download PDFInfo
- Publication number
- CN101432041A CN101432041A CNA2006800155097A CN200680015509A CN101432041A CN 101432041 A CN101432041 A CN 101432041A CN A2006800155097 A CNA2006800155097 A CN A2006800155097A CN 200680015509 A CN200680015509 A CN 200680015509A CN 101432041 A CN101432041 A CN 101432041A
- Authority
- CN
- China
- Prior art keywords
- target pathway
- pathway structure
- signal
- waveform
- therapy equipment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000037314 wound repair Effects 0.000 title claims abstract description 42
- 238000000034 method Methods 0.000 title claims abstract description 33
- 238000011282 treatment Methods 0.000 title claims description 32
- 230000003190 augmentative effect Effects 0.000 title abstract 2
- 230000037361 pathway Effects 0.000 claims abstract description 81
- 230000008878 coupling Effects 0.000 claims abstract description 26
- 238000010168 coupling process Methods 0.000 claims abstract description 26
- 238000005859 coupling reaction Methods 0.000 claims abstract description 26
- 230000001684 chronic effect Effects 0.000 claims abstract description 6
- 230000009442 healing mechanism Effects 0.000 claims abstract description 5
- 230000001154 acute effect Effects 0.000 claims abstract 3
- 210000004027 cell Anatomy 0.000 claims description 49
- 210000001519 tissue Anatomy 0.000 claims description 37
- 206010052428 Wound Diseases 0.000 claims description 35
- 208000027418 Wounds and injury Diseases 0.000 claims description 34
- 239000011575 calcium Substances 0.000 claims description 31
- 230000000694 effects Effects 0.000 claims description 29
- 230000035876 healing Effects 0.000 claims description 26
- 210000000056 organ Anatomy 0.000 claims description 26
- 230000006698 induction Effects 0.000 claims description 24
- 238000000940 electromagnetic therapy Methods 0.000 claims description 23
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 22
- 102000013275 Somatomedins Human genes 0.000 claims description 22
- 102000004127 Cytokines Human genes 0.000 claims description 16
- 108090000695 Cytokines Proteins 0.000 claims description 16
- 230000033115 angiogenesis Effects 0.000 claims description 14
- 230000001105 regulatory effect Effects 0.000 claims description 10
- 206010029113 Neovascularisation Diseases 0.000 claims description 9
- 230000017531 blood circulation Effects 0.000 claims description 9
- 102000000584 Calmodulin Human genes 0.000 claims description 7
- 108010041952 Calmodulin Proteins 0.000 claims description 7
- 230000001133 acceleration Effects 0.000 claims description 7
- 230000007246 mechanism Effects 0.000 claims description 7
- 230000008467 tissue growth Effects 0.000 claims description 7
- 238000002560 therapeutic procedure Methods 0.000 claims description 5
- 230000024883 vasodilation Effects 0.000 claims description 5
- 206010011985 Decubitus ulcer Diseases 0.000 claims description 4
- 206010056340 Diabetic ulcer Diseases 0.000 claims description 4
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims description 4
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims description 4
- 208000004210 Pressure Ulcer Diseases 0.000 claims description 4
- 208000000558 Varicose Ulcer Diseases 0.000 claims description 4
- 229940126864 fibroblast growth factor Drugs 0.000 claims description 4
- 239000003102 growth factor Substances 0.000 claims description 4
- 238000012423 maintenance Methods 0.000 claims description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 3
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 claims description 3
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 claims description 3
- 230000004520 agglutination Effects 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- 238000002224 dissection Methods 0.000 claims description 3
- 230000001939 inductive effect Effects 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000007620 mathematical function Methods 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims description 3
- 238000012546 transfer Methods 0.000 claims description 2
- 230000000739 chaotic effect Effects 0.000 claims 2
- 238000001816 cooling Methods 0.000 claims 2
- 238000010438 heat treatment Methods 0.000 claims 2
- 238000002054 transplantation Methods 0.000 claims 2
- 102000015696 Interleukins Human genes 0.000 claims 1
- 108010063738 Interleukins Proteins 0.000 claims 1
- 230000011664 signaling Effects 0.000 abstract 1
- 150000002500 ions Chemical class 0.000 description 44
- 241001465754 Metazoa Species 0.000 description 30
- 210000002435 tendon Anatomy 0.000 description 24
- 230000008439 repair process Effects 0.000 description 17
- 230000002085 persistent effect Effects 0.000 description 14
- 238000013459 approach Methods 0.000 description 13
- 230000008859 change Effects 0.000 description 12
- 230000001965 increasing effect Effects 0.000 description 12
- 229910052751 metal Inorganic materials 0.000 description 12
- 239000002184 metal Substances 0.000 description 12
- 206010030113 Oedema Diseases 0.000 description 11
- 238000001228 spectrum Methods 0.000 description 11
- 210000000988 bone and bone Anatomy 0.000 description 10
- 210000000170 cell membrane Anatomy 0.000 description 10
- 210000000707 wrist Anatomy 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- 230000004071 biological effect Effects 0.000 description 8
- 230000005684 electric field Effects 0.000 description 8
- 230000036407 pain Effects 0.000 description 8
- 230000035479 physiological effects, processes and functions Effects 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- 230000029663 wound healing Effects 0.000 description 8
- 238000004980 dosimetry Methods 0.000 description 7
- 230000005672 electromagnetic field Effects 0.000 description 7
- 238000013178 mathematical model Methods 0.000 description 7
- 230000003252 repetitive effect Effects 0.000 description 7
- 210000004872 soft tissue Anatomy 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 230000001413 cellular effect Effects 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- 210000000474 heel Anatomy 0.000 description 6
- 230000002757 inflammatory effect Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000026731 phosphorylation Effects 0.000 description 6
- 238000006366 phosphorylation reaction Methods 0.000 description 6
- 230000003595 spectral effect Effects 0.000 description 6
- 230000026683 transduction Effects 0.000 description 6
- 238000010361 transduction Methods 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 230000002349 favourable effect Effects 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 102100035044 Myosin light chain kinase, smooth muscle Human genes 0.000 description 4
- 108010074596 Myosin-Light-Chain Kinase Proteins 0.000 description 4
- 206010047139 Vasoconstriction Diseases 0.000 description 4
- 239000003990 capacitor Substances 0.000 description 4
- 230000004663 cell proliferation Effects 0.000 description 4
- 230000002596 correlated effect Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 230000001951 hemoperfusion Effects 0.000 description 4
- 210000003041 ligament Anatomy 0.000 description 4
- 239000000376 reactant Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 230000025033 vasoconstriction Effects 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 3
- 102000003505 Myosin Human genes 0.000 description 3
- 108060008487 Myosin Proteins 0.000 description 3
- 241000053227 Themus Species 0.000 description 3
- 230000004640 cellular pathway Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000005518 electrochemistry Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000002683 foot Anatomy 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- 229960003299 ketamine Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000001151 other effect Effects 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- 208000004550 Postoperative Pain Diseases 0.000 description 2
- 210000001361 achilles tendon Anatomy 0.000 description 2
- 239000003637 basic solution Substances 0.000 description 2
- 230000031018 biological processes and functions Effects 0.000 description 2
- 210000000459 calcaneus Anatomy 0.000 description 2
- 230000033077 cellular process Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000013043 chemical agent Substances 0.000 description 2
- 238000001311 chemical methods and process Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 210000003298 dental enamel Anatomy 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- HRLIOXLXPOHXTA-NSHDSACASA-N dexmedetomidine Chemical compound C1([C@@H](C)C=2C(=C(C)C=CC=2)C)=CN=C[N]1 HRLIOXLXPOHXTA-NSHDSACASA-N 0.000 description 2
- 229960004253 dexmedetomidine Drugs 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 230000005426 magnetic field effect Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 230000000399 orthopedic effect Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000012453 sprague-dawley rat model Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000036962 time dependent Effects 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 230000000472 traumatic effect Effects 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- XNCSCQSQSGDGES-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]propyl-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)C(C)CN(CC(O)=O)CC(O)=O XNCSCQSQSGDGES-UHFFFAOYSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 101000584177 Homo sapiens Myosin light chain kinase 3 Proteins 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 239000012741 Laemmli sample buffer Substances 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 102000016349 Myosin Light Chains Human genes 0.000 description 1
- 108010067385 Myosin Light Chains Proteins 0.000 description 1
- 102100030783 Myosin light chain kinase 3 Human genes 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 101150092843 SEC1 gene Proteins 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 229940064804 betadine Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000010478 bone regeneration Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- UAIXRPCCYXNJMQ-RZIPZOSSSA-N buprenorphine hydrochlorie Chemical compound [Cl-].C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)C[NH+]2CC1CC1 UAIXRPCCYXNJMQ-RZIPZOSSSA-N 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000003725 endotheliocyte Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000009483 enzymatic pathway Effects 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000004317 gizzard Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000002977 intracellular fluid Anatomy 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000001699 lower leg Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- HRLIOXLXPOHXTA-UHFFFAOYSA-N medetomidine Chemical compound C=1C=CC(C)=C(C)C=1C(C)C1=CN=C[N]1 HRLIOXLXPOHXTA-UHFFFAOYSA-N 0.000 description 1
- 229960002140 medetomidine Drugs 0.000 description 1
- 150000002739 metals Chemical group 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000001582 osteoblastic effect Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000003200 peritoneal cavity Anatomy 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001084 poly(chloroprene) Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000001258 synovial membrane Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
Images
Landscapes
- Magnetic Treatment Devices (AREA)
Abstract
A method for augmenting acute and chronic wound repair comprising the steps of configuring at least one waveform having at least one waveform parameter (step 101), selecting a value of said at least one waveform parameter of said at least one waveform to maximize at least one of a signal to noise ratio and a Power signal to noise ratio (step 102), in a target pathway structure, using said at least one waveform that maximizes said at least one of a signal to noise ratio and a Power signal to noise ratio in a target pathway structure (step 103), to generate an electromagnetic signal, and coupling said electromagnetic signal to said target pathway structure to accelerate healing mechanisms (step 104).
Description
Technical field
The present invention relates to interaction, strengthen the wound repair in people, the plant and animal by the electromagnetic environment of change and living tissue, cell and molecule.The invention still further relates to the method for regulating cell and tissue growth, reparation, maintenance and general behavior by the electromagnetic information of using coding.Especially, the active coupling of the surgery noinvasive of the present invention by the electromagnetic information of encoding provides the application to one or more body parts of very specific electromagnetic frequency (EMF) signal pattern.Electromagnetic waveforms can be used for strengthening wound repair to for example this application of people such as cell, organ, tissue and molecule, animal and plant target pathway structure.
Background technology
The use of most of low frequency EMF combines with the application of bone repair (repair) and healing (healing).Like this, the current orthopedic clinical of EMF waveform and EMF waveform is used and is comprised relative low frequency component and very low power is arranged, and causes the maximum field in every centimetre one microvolt (mv/cm) scope at the frequency place that is lower than 5KHz.Using the electrochemistry model of cell membrane to predict can to expect the linear physico-chemical process of scope of the EMF waveform patterns of biological effect, is to be the basis that is assumed to be of possible EMF target with cell membrane (particularly be combined in the cell membrane or on ion).Therefore, must determine the scope of waveform parameter, for this waveform parameter, induction field can electrochemically be coupled at cell surface for example by using the kinetics that relies on voltage.The expansion of this linear model comprises Lorentz (Lorentz) power Consideration, and its magnetic component that has finally confirmed EMF can play an important role in the EMF treatment.This causes in very low frequency range from the AC of merging and the ion cyclotron resonance and the quantum model of DC magnetic field effect prediction interests.
Continuous sinusoidal wave pulse radiation frequency (PRF) signal that produces by the 27.12MHz that is used for the deep tissues healing is known in the prior art field of diathermy.The follow-up thing of the pulse of diathermy signal is delivered at first to can excite the electromagnetic field of non-thermal biological effect in the treatment of infectious disease.Subsequently, reported PRF treatment application, be used for reducing after the wound and the edema of postoperative pain and soft tissue, wound healing, burn treatment and neuranagenesis.The application of PRF of traumatic edema of being used to disappear is used in recent years more and more.In animal and clinical research, use the result of PRF to show that edema can moderately be reduced owing to such electromagnetic stimulation so far.
The present invention is based on biophysics and zooscopy, it exchanges effect to organizational structure sensitivity owing to induced voltage and correlated current with cell and cell.Whether the EMF signal that the mathematical analysis of at least one in use signal to noise ratio (snr) and the PSNR power signal-to-noise ratio (Power SNR), estimation are applied to target pathway structure (as cell, tissue, organ and molecule) is detectable on the thermal noise of ions binding position appearance.The dielectric characteristic of organizational structure is not considered in the EMF dosimetry of prior art, and on the contrary, prior art is utilized the characteristic of isolated cells.By utilizing dielectric characteristic, the activity coupling (reactive coupling) of the electromagnetic waveforms that SNR that estimates in the target pathway structure by optimization and Power SNR mathematical value dispose can strengthen: the reparation of people, animal and plant cell, organ, tissue and intramolecular various wounds (for example behind the surgical operation and the wound healing of wound), angiogenesis, the hemoperfusion that improves, vasodilation, vasoconstriction, decrease in edema, enhanced neovascularization, bone repair, tendon reparation, ligament repair, neomorph, and pain relief.Wound repair enhancement results comes from the blood flow of increase and adjusting and other enhanced biological effect process of angiogenesis and neovascularization.
Noinvasive PRF utilizes the impulse train of 27.12MHz sine wave in the nearest clinical use of radio frequency, the general width of showing 65 microseconds of each impulse train, and nearly 1700 sinusoidal period of every impulse train, and have different burst repetition rate.
Broad spectral density bursts with electromagnetic waveforms of the frequency in the scope of one to 100 megahertz (MHz) is selectively used for people, animal and plant cell, organ, tissue and molecule, every impulse train has 1 to 100,000 pulse, and burst repetition rate is 0.01 to 10,000 hertz (Hz).The voltage amplitude envelope of each impulse train be at random, the function of irregular or other like variable, be used in pulse burst envelope, providing broad-spectrum density.By the mathematical function of the signal of consideration in specific target pathway structure, come defined variable with thermal noise ratio and Power SNR.Waveform Design becomes to regulate living cells growth, state and reparation.The application-specific of these signals includes but not limited to: strengthen the treatment of organ, muscle, joint, skin and hair, and behind the surgical operation and the wound healing of wound, angiogenesis, the hemoperfusion that improves, vasodilation, vasoconstriction, decrease in edema, enhanced neovascularization, bone repair, tendon reparation, ligament repair, neomorph, and pain relief.The application of electromagnetic waveforms can be used for strengthening the healing of various wounds.
According to embodiment of the present invention, the pulse burst envelope of higher spectral density can more effectively be coupled to the dielectric pathways that the physiology is correlated with, for example cell-membrane receptor, change with bonded ion of cellular enzymes and general transmembrane potential.Increased the quantity of the frequency component that is transferred to relevant cellular pathways according to embodiment of the present invention, the biophysics phenomenon in a big way that causes can be applicable to known healing mechanism becomes and can realize, comprises enhanced enzymatic activity, growth factor release and release of cytokines.By increasing the impulse train persistent period, with by use at random or the envelope of other high spectrum density to the pulse burst envelope of one pole or bipolar rectangle or sine pulse, can obtain can be applicable to the soft tissue in people, the animal and plant and the more effective and bigger effect of biological healing process of sclerous tissues, thereby cause the acceleration of wound repair, this one pole or bipolar rectangle or sine pulse induction are at every centimetre 10
-6And the peak value electric field between 10 volts (V/cm), and satisfied detectability requirement according to SNR or Power SNR.
The present invention relates to the mechanisms known of wound repair, it relates to the periodic naturally release that is applied to somatomedin suitable in each stage of people, animal and plant or cytokine in wound repair.Especially, wound repair comprises that inflammatory phase, angiogenesis, cell proliferation, collagen produce and the reconstruction phase.There is the timing of specific cytokine and somatomedin to discharge in each stage.Electromagnetic field can strengthen blood flow and strengthen ions binding, and this can quicken each healing stage conversely.Special purpose of the present invention provides improved device and repairs with the effect and the acceleration that strengthen exogenous factor.Use a favourable result of the present invention to be, but because blood flow strengthen or chemical-biological activities strengthens thereby accelerate wound repair.The method that the purpose of this invention is to provide improvement to be promoting Expected Results, or improves the relevant cytokine of each stage of wound repair and effect and other effect of somatomedin.
Another object of the present invention is to cause and quicken the healing of chronic wounds, as the non-healing wound of diabetic ulcer, venous stasis ulcers, pressure ulcer and any cause.
Another object of the present invention is, by high spectrum density voltage envelope being applied as adjusting or the impulse train defined parameters that requires according to SNR and Power SNR, can be starkly lower than the power requirement than short burst of pulse to the power requirement of the impulse train of such increase persistent period with same frequency range; This comes from the more effective coupling of frequency component and relevant cellular/molecular process.Therefore, obtained the advantage of the power requirement of enhanced dosimetry that is transferred to relevant dielectric pathways and reduction.
Therefore, exist the equipment that more effectively quickens the wound repair in people, animal and plant cell, organ, tissue and the molecule and the needs of method.
Summary of the invention
The use of most of low frequency EMF combines with the application of bone repair and healing.Like this, the current orthopedic clinical use of EMF waveform and EMF waveform comprises relative low frequency component and very low power is arranged, and causes the maximum field in every centimetre one microvolt (mv/cm) scope at the frequency place that is lower than 5KHz.The linear physico-chemical process of scope that uses the electrochemistry model of cell membrane to predict can to expect the EMF waveform patterns of biological effect is to be the basis that is assumed to be of possible EMF target with cell membrane (particularly be combined in the cell membrane or on ion).Therefore, must determine the scope of waveform parameter, for this waveform parameter, induction field can be for example by using the kinetics that relies on voltage electrochemically to be coupled at cell surface.The expansion of this linear model comprises Lorentz (Lorentz) power Consideration, and its magnetic component that has finally confirmed EMF can play an important role in the EMF treatment.This causes in very low frequency range from the AC of merging and the ion cyclotron resonance and the quantum model of DC magnetic field effect prediction interests.
Continuous sinusoidal wave pulse radiation frequency (PRF) signal that produces by the 27.12MHz that is used for the deep tissues healing is known in the prior art field of diathermy.The follow-up thing of the pulse of diathermy signal is delivered at first to can excite the electromagnetic field of non-thermal biological effect in the treatment of infectious disease.Subsequently, reported PFR treatment application, be used for reducing after the wound and the edema of postoperative pain and soft tissue, wound healing, burn treatment and neuranagenesis.The application of PRF of traumatic edema of being used to disappear is used in recent years more and more.In animal and clinical research, use the result of PRF to show that edema can moderately be reduced owing to such electromagnetic stimulation so far.
The present invention is based on biophysics and zooscopy, it exchanges effect to organizational structure sensitivity owing to induced voltage and correlated current with cell and cell.Whether the EMF signal that the mathematical analysis of at least one in use signal to noise ratio (snr) and the PSNR power signal-to-noise ratio (Power SNR), estimation are applied to target pathway structure (as cell, tissue, organ and molecule) is detectable on the thermal noise of ions binding position appearance.The dielectric characteristic of organizational structure is not considered in the EMF dosimetry of prior art, and on the contrary, prior art is utilized the characteristic of isolated cells.By utilizing dielectric characteristic, the activity coupling of the electromagnetic waveforms that SNR that estimates in the target pathway structure by optimization and Power SNR mathematical value dispose can strengthen: the reparation of people, animal and plant cell, organ, tissue and intramolecular various wounds (for example behind the surgical operation and the wound healing of wound), angiogenesis, the hemoperfusion that improves, vasodilation, vasoconstriction, decrease in edema, enhanced neovascularization, bone repair, tendon reparation, ligament repair, neomorph, and pain relief.Wound repair enhancement results comes from the blood flow of increase and adjusting and other enhanced biological effect process of angiogenesis and neovascularization.
Noinvasive PRF utilizes the impulse train of 27.12MHz sine wave in the nearest clinical use of radio frequency, the general width of showing 65 microseconds of each impulse train, and nearly 1700 sinusoidal period of every impulse train, and have different burst repetition rate.
Broad spectral density bursts with electromagnetic waveforms of the frequency in the scope of one to 100 megahertz (MHz) is selectively used for people, animal and plant cell, organ, tissue and molecule, every impulse train has 1 to 100000 pulse, and burst repetition rate is 0.01 to 10000 hertz (Hz).The voltage amplitude envelope of each impulse train be at random, the function of irregular or other similar variable effect, be used in pulse burst envelope, providing broad-spectrum density.By the mathematical function of the signal of consideration in specific target pathway structure, come defined variable with thermal noise ratio and Power SNR.Waveform Design becomes to regulate living cells growth, state and reparation.The application-specific of these signals includes but not limited to: strengthen the treatment of organ, muscle, joint, skin and hair, and behind the surgical operation and the wound healing of wound, angiogenesis, the hemoperfusion that improves, vasodilation, vasoconstriction, decrease in edema, enhanced neovascularization, bone repair, tendon reparation, ligament repair, neomorph, and pain relief.The application of electromagnetic waveforms can be used for strengthening the healing of various wounds.
According to embodiment of the present invention, the pulse burst envelope of higher spectral density can more effectively be coupled to the dielectric pathways that the physiology is correlated with, for example cell-membrane receptor, change with bonded ion of cellular enzymes and general transmembrane potential.Increased the quantity of the frequency component that is transferred to relevant cellular pathways according to embodiment of the present invention, the biophysics phenomenon in a big way that causes can be applicable to known healing mechanism becomes and can realize, comprises enhanced enzymatic activity, growth factor release and release of cytokines.By increasing the impulse train persistent period, with by use at random or the envelope of other high spectrum density to the pulse burst envelope of one pole or bipolar rectangle or sine pulse, can obtain can be applicable to the soft tissue in people, the animal and plant and the more effective and bigger effect of biological healing process of sclerous tissues, thereby cause the acceleration of wound repair, this one pole or bipolar rectangle or sine pulse induction are at every centimetre 10
-6And the peak value electric field between 10 volts (V/cm), and satisfied detectability requirement according to SNR or Power SNR.
The present invention relates to the mechanisms known of wound repair, it relates to the periodic naturally release of somatomedin suitable in each stage of the wound repair that is applied to people, animal and plant or cytokine.Especially, wound repair comprises that inflammatory phase, angiogenesis, cell proliferation, collagen produce and the reconstruction phase.There is the timing of specific cytokine and somatomedin to discharge in each stage.Electromagnetic field can strengthen blood flow and strengthen ions binding, and this can quicken each healing stage conversely.Special purpose of the present invention provides improved device and repairs with the effect and the acceleration that strengthen exogenous factor.Use a favourable result of the present invention to be, but because blood flow strengthen or chemical-biological activities strengthens thereby accelerate wound repair.The method that the purpose of this invention is to provide improvement to be promoting the Expected Results of each stage relevant cell factor of wound repair and somatomedin, or improves the relevant cytokine of each stage of wound repair and effect and other effect of somatomedin.
Another object of the present invention is to impel and quicken the healing of chronic wounds, as the non-healing wound of diabetic ulcer, venous stasis ulcers, pressure ulcer and any cause.
Another object of the present invention is, by high spectrum density voltage envelope being applied as adjusting or the impulse train defined parameters that requires according to SNR and Power SNR, can be starkly lower than the power requirement than short burst of pulse to the power requirement of the impulse train of such increase persistent period with same frequency range; This comes from the more effective coupling of frequency component and relevant cellular/molecular process.Therefore, obtained the advantage of the power requirement of enhanced dosimetry that is transferred to relevant dielectric pathways and reduction.
Therefore, exist the equipment that more effectively quickens the wound repair in people, animal and plant cell, organ, tissue and the molecule and the needs of method.
Description of drawings
Below with reference to accompanying drawing the preferred embodiments of the invention are described in more detail:
Fig. 1 is the flow chart of method that is used for quickening the wound repair of living tissue, cell and molecule according to embodiments of the present invention;
Fig. 2 is the view that is applied to kneed control circuit and electric coil according to the preferred embodiment of the invention;
Fig. 3 is the structure chart according to the miniaturized circuit of the preferred embodiment of the invention;
Fig. 4 A is according to the wire coil of the preferred embodiment of the invention such as the string diagram of induction apparatus:
Fig. 4 B is the string diagram according to the flexible magnetic wire of the preferred embodiment of the invention;
Fig. 5 describes to be delivered to for example waveform of molecule, cell, tissue or organ of target pathway structure according to the preferred embodiment of the invention;
Fig. 6 is according to the positioning equipment of the preferred embodiment of the invention such as the view of wrist support;
Fig. 7 is according to the positioning equipment of the preferred embodiment of the invention such as the view of mattress cushion;
Fig. 8 is the view that shows positioning equipment according to embodiments of the present invention such as corset;
Fig. 9 is the curve chart of the myosin phosphorylation of increase to greatest extent that shows the PMRF signal of configuration according to an embodiment of the present invention.
The specific embodiment
Provide higher spectrum density according to embodiment of the present invention to pulse burst envelope, caused the enhanced treatment of cell-membrane receptor for example, the dielectric pathways relevant with bonded ion of cellular enzymes and general transmembrane potential variation etc. is renderd a service.Increased the quantity of the frequency component that is transferred to the relevant cell approach according to embodiment of the present invention, thereby the chance that provides contact to can be applicable in a big way the biophysics phenomenon of known healing mechanism, for example adjusting of somatomedin and release of cytokines and in the ions binding of regulating the molecule place.According to by at the SNR of transduction in (transduction) approach or the mathematical model of Power SNR definition, by the general at random or other high spectrum density envelope be applied to induction at every centimetre 10
-6And the pulse burst envelope of the one pole of the peak value electric field between 10 volts (V/cm) or bipolar rectangle or sine pulse, can reach bigger effect to the biological agglutination that can be applicable to soft tissue and sclerous tissues.
A favourable outcome of the present invention is, according to mathematical model by SNR in transduction pathway or Power SNR definition, by using high spectrum density voltage envelope, can be starkly lower than the power requirement of the unmodulated impulse train that is included in the pulse in the identical frequency range to the power requirement of such amplitude adjusted impulse train as regulating or the impulse train defined parameters.Therefore, obtained the advantage of the power requirement of enhanced dosimetry that is transferred to relevant dielectric target approach and reduction.Another advantage of the present invention is an accelerate wound repair.
The mechanisms known of wound repair relates to the periodic naturally release of somatomedin suitable in each stage of the wound repair that is applied to people, animal and plant or cytokine.Especially, wound repair comprises that inflammatory phase, angiogenesis, cell proliferation, collagen produce and the reconstruction phase.There is the timing of specific cytokine and somatomedin to discharge in each stage.Electromagnetic field is considered to strengthen blood flow and strengthens ions binding, and this can quicken each healing stage conversely.The purpose of this invention is to provide improved device, with the effect of enhancing each stage relevant cell factor of wound repair and somatomedin, and promote its Expected Results, or improve its effect and other effect.
The electric current that changes from sensitive time of PEMF or PRF equipment for example flows in molecule, cell, tissue and the organ in the target pathway structure, and these electric currents are a kind of stimulations, and cell and tissue can react to this stimulation with physiology's meaningful ways.The electrical characteristics of target pathway structure influence faradic level and distribution.Molecule, cell, tissue and organ all are in the faradic current approach, are in the slot engagement contact as cell.At the ion that can reside in the binding site place on the lip-deep macromole of film or ligand interaction is can be in response to the process of the dependence voltage of induction field (E), for example electrochemistry.Faradic current arrives these positions by ionic medium on every side.The existence of cell in current pathway makes faradic current (J) along with the time (J (t)) decays comparatively fast.This be since from conjunction with and the electrical impedance of the cell of the membrane capacitance of other voltage-sensitive membrane process such as film transhipment and time constant increase.
The equivalent-circuit model of representing different films and charged interface configurations is obtained.For example, at calcium (Ca
2+) in conjunction with in since the induction E, the bonded Ca at the binding site place
2+Concentration change can be in frequency domain describe by impedance expression, as:
It has the form of the equivalent circuit of series resistance-electric capacity.Wherein ω is the angular frequency that is defined as 2 π f, and f is a frequency, i=-1
1/2, Z
b(ω) be combined impedance, and R
IonAnd C
IonBe the electric capacity of equivalence in conjunction with resistance and ions binding approach.The value τ of equivalence binding time constant
Ion=R
IonC
IonPass through τ
Ion=R
IonC
Ion=1/k
bRelevant with ions binding rate constant.Therefore, the characteristic time constant of this approach is determined by ions binding kinetics.
Induction E from PEMF or PRF signal can make electric current flow into the ions binding approach, and influences the bonded Ca of time per unit
2+Ionic quantity.Its electrical equivalent is in conjunction with capacitor C in equivalence
IonThe change in voltage at two ends, this is by C
IonThe direct measurement of the change in electrical charge that stores.Electric charge and Ca in binding site
2+Ionic surface concentration is in direct ratio, that is, the storage of electric charge is equivalent to ion or the storage of other charged matter on cell surface and joint.The direct driving force credit of impedance bioelectrical measurement and combination rate constant is analysed, and provides to configuration PMF waveform leads to the band with the target pathway structure to mate the time necessary constant value.This considers the desired frequency range of any given induction E waveform, arrives the target impedance with Best Coupling, as be with logical.
With regulating the bonded ion of molecule is common EMF target, for example with the bonded Ca of calmodulin, CaM
2+(CaM).The use of this approach is based on acceleration of tissue repair, for example reparation of bone healing, wound healing, hair reparation and molecule, cell, tissue and organ, and these reparations relate to the adjusting of repairing interim d/d somatomedin in difference.Somatomedin, for example platelet derived growth factor (PDGF), fibroblast growth factor (FGF) and epidermal growth factor (EGF) are all related in the suitable healing stage.Angiogenesis and neovascularization are also essential to tissue growth and reparation, and can be regulated by PMF.All these factors all have the Ca/CaM dependency.
Utilize the configurable waveform of Ca/CaM approach, for this waveform, induced power is fully greater than the background heat noise power.Under suitable physiological condition, this waveform can have significant biological effect on physiology.
Power SNR model is to the application need of the Ca/CaM Ca at CaM
2+The knowledge of the electrical equivalent of binding kinetics.In the one-level binding kinetics, at the bonded Ca of CaM binding site
2+Concentration over time can be by equivalent binding time constant τ in frequency domain
Ion=R
IonC
IonCharacterization, wherein R
IonAnd C
IonBe the electric capacity of equivalence in conjunction with resistance and ions binding approach.τ
IonPass through τ
Ion=R
IonC
Ion=1/k
bWith ions binding rate constant k
bRelevant.k
bPublished value can be used on then in the cellular array model, to estimate SNR by the voltage that relatively causes by the PRF signal and heat fluctuation at the voltage of CaM binding site.Use the digital value of using of PMF response, as V
Max=6.5 x 10
-7Sec
-1, [Ca
2+]=2.5 μ M, K
D=30 μ M, [Ca
2+CaM]=K
D([Ca
2+]+[CaM]), obtain k
b=665sec
-1(τ
Ion=1.5msec).Such τ
IonValue can be used in the equivalent circuit of ions binding, and the Power SNR analysis can be performed for any waveform configuration.
According to embodiment of the present invention, mathematical model, for example mathematical equation and/or a series of mathematical equation can be configured to absorb the thermal noise that appears in all processes relevant with voltage, and the expression set up enough SNR the minimum threshold requirement.For example, the power spectral density that mathematical model that the minimum threshold of enough SNR requires can be configured to comprise thermal noise is set up in expression, so the power spectral density S of thermal noise
n(ω) can be expressed as:
S
n(ω)＝4kTRe[Z
M(x，ω)]
Z wherein
M(x ω) is the electrical impedance of target pathway structure, and x is the dimension of target pathway structure, and Re represents the real part of impedance of target pathway structure.Z
M(x ω) can be expressed as:
This equation is clearly shown that the electrical impedance of target pathway structure and all promotes noise filtering from the contribution of extracellular fluid bulk resistor (Re), intracellular fluid bulk resistor (Ri) and intermembranous resistance (Rg) that these resistance are electrically connected to the target pathway structure.
Estimate the monodrome of conventional method use root-mean-square (RMS) noise voltage of SNR.This is by getting S on all relevant with complete film reaction or relevant with the bandwidth of target pathway structure frequencies
n(ω)=4kTRe[Z
M(x, ω)] the square root of integration calculate.SNR can be represented by ratio:
Wherein | V
M(ω) | be when chosen Frequency Transfer amplitude peak at each frequency place voltage when the target pathway structure.
Embodiment of the present invention comprise the pulse burst envelope with high spectrum density so that strengthen therapeutic effect to relevant dielectric pathways, as cell-membrane receptor, with the bonded ion of cellular enzymes and transmembrane potential change.Therefore, be transferred to a lot of frequency components of relevant cellular pathways by increase, the large-scale biophysics phenomenon that can be applicable to known tissue growth mechanism is attainable, for example can be applicable to the adjusting somatomedin of known tissue growth mechanism and release of cytokines and in the ions binding of regulating molecule.According to embodiment of the present invention, will be at random or other high spectrum density envelope be applied to induction about 10
-8And the one pole of the peak value electric field between about 100 volts of V/cm or the pulse burst envelope of bipolar rectangle or sine pulse, the biological agglutination that can be applicable to soft tissue and sclerous tissues is produced bigger effect.
According to another embodiment of the present invention, regulate or the impulse train defined parameters by high spectrum density voltage envelope is applied as, can be starkly lower than the not regulating impulse group's of the pulse that comprises in the similar frequencies scope power requirement to the power requirement of the impulse train of such amplitude adjusted.This be because, by with irregular, at random the amplitude of being preferably is imposed to otherwise be essentially uniform pulse burst envelope, has produced the substantial minimizing in the intrachain dutycycle of repetitive burst.Therefore, obtained the two-fold advantage of the power requirement of enhanced dosimetry that is transferred to the relevant dielectric approach and reduction.
With reference to figure 1, wherein Fig. 1 is the flow chart according to the method for embodiment of the present invention, and for the purpose for the treatment of and preventing, this method is used for by being delivered to the target pathway structure by the electromagnetic signal of pulsed, ion and part as the animal and human come accelerate wound repair.The target pathway structure also can include but not limited to tissue, cell, organ and molecule.
At least one contoured configuration that will have at least one waveform parameter becomes to be coupled to the target pathway structure, as ion and part (step 101).
Described at least one waveform parameter is chosen to maximize in signal to noise ratio in the target pathway structure and the PSNR power signal-to-noise ratio at least one, so that waveform is detectable (step 102) on background activity in the target pathway structure, background activity for example fluctuates at the voltage and the elementary heat in the electrical impedance of target pathway structure, this depends on the state of cell and tissue, promptly, whether this state is at least a of rest, growth, displacement and response damage, to be created in useful result on the physiology.In order in the target pathway structure, to be detectable, the value of described at least one waveform parameter can be selected by the constant that uses described target pathway structure, come in estimated snr and the PSNR power signal-to-noise ratio at least one, to compare elementary heat fluctuation by the voltage of described at least one waveform influence in described target pathway structure and voltage in described target pathway structure and electrical impedance, thus by the band of maximization in described target pathway structure in described signal to noise ratio in logical and the PSNR power signal-to-noise ratio at least one, by means of described at least one waveform, biological effect adjusts in the present described target pathway structure.
The preferred embodiment of the electromagnetic signal that is produced comprises the impulse train of the random waveform with at least one waveform parameter, this waveform parameter comprises the frequency component of a plurality of scopes from about 0.01Hz to about 100MHz, and wherein said a plurality of frequency components satisfy Power SNR model (step 103).For example multiple electromagnetic signal can be by described at least one waveform inductive or generation (step 104) capacitively.Electromagnetic signal also can be non-repeatability.Electromagnetic signal is by the output of the Coupling device (as electrode or induction apparatus) closely placed with the target pathway structure utmost point, and is coupled to the target pathway structure, as ion and part (step 105).This coupling has increased the bonded adjusting of adjusting molecule in blood flow and ion and part and molecule, tissue, cell and the organ, thereby has quickened wound repair.
Fig. 2 illustrates the preferred embodiment according to equipment of the present invention.This equipment be independently, light-duty with portative.Small-sized control circuit 201 is coupled to the end of at least one adapter 202 as metal wire, but but also radio operation of control circuit.Generating equipment is coupled in the opposite end of described at least one adapter, as electric coil 203.Small-sized control circuit 201 constitutes in the mode of applied mathematical model, and this model is used for configure waveforms.The waveform that is disposed must satisfy Power SNR, so that for given and known target pathway structure, might select to satisfy the waveform parameter of Power SNR, make on the waveform generation physiology useful result (adjusting of biological example effect) and be detectable in the target pathway structure on background activity.According to the preferred embodiments of the invention applied mathematical model, come induction mM disodium hydrogen phosphate and time dependent electric field in target pathway structure (as ion and part), comprise that arriving about 0.1 of about 100 microsecond rectangular pulses with per second about 0.1 to about 100 pulses multiple about 1 arrives about 100 milliseconds impulse train.The peak amplitude of induction field is between about 1 μ V/cm and about 100mV/cm, according to the 1/f equation variation of change, wherein f=frequency.Be configured to use the waveform according to the preferred embodiments of the invention to can be applicable in the target pathway structure (as ion and part), preferred total irradiation time is 1 minute to 240 minutes every day.Yet can use other irradiation time.Waveform by small-sized control circuit 201 configurations is directed into generating equipment 203 as electric coil by adapter 202.Generating equipment 203 transmission can be used for providing to target pathway structure such as tissue the pulsed magnetic field of treatment.The one section official hour in small-sized control circuit apply pulse magnetic field, and can be by needed (for example a day 10 times) and the repeated application pulsed magnetic field automatically repeatedly used in the given time period.The small-sized control circuit in repetitive sequence apply pulse magnetic field can be configured to programmable with any time.Can come accelerate wound repair by merging in the positioning equipment 204 (as bed) according to the preferred embodiments of the invention.Pulsed magnetic field is coupled to target pathway structure such as ion and part, on treatment and prevent disease, has reduced inflammation, thereby advantageously reduced pain, quickened the healing in the target site.When electric coil is used as generating equipment 203,, can utilize the mM disodium hydrogen phosphate of the time dependent electric field of induction in the target pathway structure to provide power to electric coil according to Faraday's law.Also can use electromagnetic coupled to use the electromagnetic signal that is produced by generating equipment 203, wherein electrode directly contacts with the other external electric conducting border of skin or target pathway structure.In addition, in another embodiment according to the present invention, also can use static to be coupled and use the electromagnetic signal that produces by generating equipment 203, wherein between generating equipment 203 is as electrode and target pathway structure such as ion and part, have the air gap.Advantage according to the preferred embodiments of the invention is that its microlight-type coil and miniaturized circuit allow to be used for the General Physics Therapeutic Method, and are used for the place of any desired growth, pain relief and tissue and organ healing.Favourable outcome according to the application of the preferred embodiments of the invention is, tissue growth, reparation and maintenance can be anywhere and finished at any time and strengthen, for example when driving or seeing TV.The another favourable outcome of the application of preferred embodiment is, the growth of molecule, cell, tissue and organ, reparation and maintenance can be anywhere and finished at any time and strengthen, for example when driving or seeing TV.
Fig. 3 has described the structure chart according to the small-sized control circuit 300 of the preferred embodiments of the invention.Small-sized control circuit 300 produces the waveform that drives generating equipment (as the top wire coil of describing) in Fig. 2.Small-sized control circuit can be triggered by any flip flop equipment (as on/off switch).Small-sized control circuit 300 has power supply such as lithium battery 301.The preferred embodiment of power supply has 3.3 volts output voltage, but also can use other voltage.In another embodiment according to the present invention, power supply can be for example current and power supply socket of external power source, as be coupled to AC/DC supply socket of the present invention by plug and electric wire.Switching Power Supply 302 controls to the voltage of microcontroller 303.The preferred embodiment of microcontroller 303 is used the microcontroller of 8 bit 4MHz, but can use the combination microcontroller of other bit MHz.Switching Power Supply 302 also can convey electrical current to reservior capacitor 304.The preferred embodiments of the invention are used the reservior capacitor with 220 μ F output, but can use other output.Reservior capacitor 304 allows high-frequency impulse to be transported to Coupling device such as induction apparatus (not shown).Microcontroller 303 also control impuls forms device 305 and impulse phase timing controlled 306.Pulse shaper 305 and impulse phase timing controlled 306 are determined pulse shape, burst width, pulse burst envelope shape and burst repetition rate.The integrated waveform generator as the generator of sine wave or any amount, also can be merged so that specific waveform to be provided.307 controls of voltage level conversion electronic circuit are delivered to the induction field of target pathway structure.Switch Hexfet 308 allows the impulse train of pulses of randomized amplitude to be passed to the output 309 that waveform is sent at least one Coupling device such as induction apparatus.Total irradiation time that microcontroller 303 is gone back the seance of may command target pathway structure such as molecule, cell, tissue and organ.Small-sized control circuit 300 can be configured to programmable and the one section official hour in apply pulse magnetic field, and can be configured to by needed repeatedly application (for example a day 10 times) in the given time period repeated application pulsed magnetic field automatically.Use about 10 minutes to about 30 minutes treatment time according to the preferred embodiments of the invention.
With reference to figure 4A and Fig. 4 B, it illustrates Coupling device 400 according to the preferred embodiments of the invention as induction apparatus.Coupling device 400 can be the electric coil 401 that twines with sub-thread or multiply flexible wire 402, yet also can use solid wire.In according to the preferred embodiments of the invention, metal wire is made of copper, but also can use other material.Multiply flexible magnetic wire 402 makes electric coil 401 can meet specific anatomical structure, as human or animal's the limb wing or joint.The preferred embodiment of electric coil 401 comprise the about 0.01mm of diameter to about 0.1mm about 1 in the sub-thread magnetic metal wire of about 1000 circles and the multiply magnetic metal wire at least one, metal wire is wrapped in outer dia on the structure that is initially circle between about 2.5cm and the about 50cm, but also can use the circle and the wire diameter of other quantity.The preferred embodiment of electric coil 401 can be wrapped up with nontoxic PVC mold 403, but also can use other non-toxic moulds.Electric coil also can be incorporated in dressing, binder, clothes and generally be used for other structure of Wound healing and bone regeneration.
With reference to figure 5, it illustrates the waveform 500 according to embodiment of the present invention.Pulse 501 repeats in the impulse train 502 with finite duration.Such persistent period 503 makes the dutycycle of the ratio that can be defined as impulse train persistent period and signal period about 1 to about 10
-5Between.Utilize accurate rectangle 10 microsecond pulses to arrive about 50 milliseconds according to the preferred embodiments of the invention as the pulse 501 about 10 that is used in the impulse train 502, impulse train 502 has the 1/f amplitude envelops 504 of change, and have, but can use other waveform, envelope and the impulse train cycle of following mathematical model such as SNR and Power SNR corresponding to about 0.1 the finite duration 503 in impulse train cycle between about 10 seconds.
Fig. 6 illustrates the positioning equipment according to the preferred embodiments of the invention, as wrist support.Positioning equipment 600 is worn on people's the wrist 602 as wrist support 601.Positioning equipment can be configured to portative, can be configured to disposablely, maybe can be configured to implantable.Positioning equipment can be used in combination with the present invention in many ways, for example, and by as Velcro
The present invention is sewed up, appends on the positioning equipment and the present invention is integrated with in the positioning equipment, and the present invention is kept in place by positioning equipment is configured to elasticity.
In another embodiment according to the present invention, the present invention can be configured to have or do not have the stand-alone device of the virtually any size of positioning equipment, to be used in Anywhere, for example is in, in the clinic, in therapeutic community or outdoor.Wrist support 601 can be with any dissection and for example neoprene manufacturing of support material.Coil 603 is integrated with in the wrist support 601, makes the signal (waveform of for example describing in Fig. 5) of the configuration according to the present invention be applied to the sole of the foot portion of wrist bottom from the back at wrist top.Use ruggedized equipment such as Velcro
(not shown) is attached to microcircuit the outside of wrist support 601.Microcircuit is coupled to an end of at least one connection device such as flexible wire 605.The other end of described at least one connection device is coupled to coil 603.Positioning equipment according to other embodiments of the present invention comprises knee joint, elbow, lower back, shoulder, other dissection wrappage and medicated clothing, for example clothes, fashion accessory and footgear.
With reference to figure 7, it illustrates the electromagnetic therapy equipment of integrating with mattress cushion 700 according to embodiment of the present invention.Also can use mattress.Some lightweight flexible coils 701 are integrated with mattress cushion.Lightweight flexible coils 701 can be made of fine and soft property conductive metal wire, conductive filament and any other flexible conducting material.Flexible coil is connected at least one end of at least one metal wire 702.Yet flexible coil also can be configured to be directly connected to circuit 703 or wireless connections.Be connected to the other end at least of described at least one metal wire according to the light-duty miniaturized circuit 703 of embodiment of the present invention configure waveforms.When triggering light-duty miniaturized circuit 703, configuration is directed into the waveform of flexible coil (701), is coupled to the PEMF signal of target pathway structure with generation.
With reference to figure 8, it illustrates the electromagnetic curing inductive devices of integrating with corset such as medicated bra according to embodiment of the present invention.Some lightweight flexible coils 801 are integrated with medicated bra.Lightweight flexible coils can be made of fine and soft property conductive metal wire, conductive filament and any other flexible conducting material.Flexible coil is connected at least one end of at least one metal wire 802.Yet flexible coil also can be configured to be directly connected to circuit 803 or wireless connections.Be connected to the other end at least of described at least one metal wire according to the light-duty miniaturized circuit 803 of embodiment of the present invention configure waveforms.When being triggered, light-duty miniaturized circuit 803 configure waveforms, this waveform is directed into flexible coil (801), is coupled to the PEMF signal of target pathway structure with generation.
Example 1
Embodiment according to the EMF of being used for signal configures of the present invention is used for the Ca-dependent myosin phosphorylation that standard enzyme is analyzed.Known this enzymatic pathway can strengthen the effectiveness that medicament, chemical agent, enamel and local agent are applied to people, animal and plant cell, organ, tissue and molecule.For the phosphorylation rate is linear in the time of a few minutes and is sub-saturated Ca
2+Concentration is come choice reaction mixture.In the time of in occurring in damage, or since use be applied on people, animal and plant cell, organ, tissue and the molecule, on or among medicament, chemical agent, enamel and local agent, this is the Ca to the EMF sensitivity
2+/ CaM has opened biological window.Use experimentizes from isolating myosin light chain of turkey gizzard (MLC) and myosin light chain kinase (MLCK).Reactant mixture mainly is made up of following material: comprise 40mMHepes buffer solution, pH and be 7.0 basic solution; 0.5mM ammonium acetate; The 1mg/ml bovine serum albumin, 0.1% (w/v) tween (Tween) 80; And 1mM EGTA.Free Ca
2+In 1-7 μ M scope, change.In case set up Ca
2+Buffering, freshly prepared 70nM CaM, 160nM MLC and 2nM MLCK are added to basic solution, to form final reactant mixture.
Reactant mixture fresh preparation every day to be being used for the experiment of each series, and is divided into the part of 100 μ L and the 1.5ml Eppendorf that packs into pipe.All Eppendorf pipes that comprise reactant mixture are maintained at 0 ℃, are transferred to specially designed bain-marie then, and bain-marie maintains 37 ± 0.1 ℃ by the lasting perfusion of the water that passes FisherScientific model 900 heat exchangers and be preheated.Use is immersed in a thermistor detector (as Cole-Parmer model 8110-20) in the Eppendorf pipe at all experimental sessions and comes monitoring temperature.Reaction starts with 2.5 μ M 32P ATP, and stops with the Laemmli sample buffer solution that comprises 30 μ MEDTA.The minima of counting five blank (blank) sample in each experiment.Blank comprises and deducts active component Ca
2+, one of CaM, MLC or MLCK whole analysis of mixtures.Blank counts surpasses the experiment of 300cpm and is abandoned.Phosphorylation was allowed to carry out 5 minutes, and by using TM analytical model 5303 Mark V liquid scintillation counters to being integrated among the MLC
32P counts and estimates phosphorylation.
Signal comprises the repetitive burst of high frequency waveforms.Amplitude maintains constant at 0.2G, and is 1 burst/sec to all irradiation repetitive rate.According to the estimation of explanation when the mathematical analysis of the present invention of time acquisition best power SNR near 500 μ sec of impulse train persistent period, the impulse train persistent period changes to 1000 μ sec from 65 μ sec.The result is presented among Fig. 9, is that the burst width 901 of unit is indicated on the x axle with μ sec wherein, and myosin phosphorylation 902 is indicated on the y axle as treatment/contrasts (treated/sham).Can see that PMF is to Ca
2+With the bonded effect of CaM when the about 500 μ sec near its maximum, just shown in Power SNR model.
These results confirm, for the impulse train persistent period of the best power SNR that is enough to obtain given magnetic field amplitude, will increase wound repair in people, animal and plant cell, organ, tissue and the molecule to greatest extent according to the EFM signal of embodiment of the present invention configuration.
Example 2
According to embodiment of the present invention, further confirm the use of Power SNR model in vivo in the wound repair model.The Mus wound model is fully characterization on biomechanics and biochemistry, and is used in this research.Utilize weight to surpass health, the young male Sprague Dawley Mus of 300 grams.
Intraperitoneal injection amount with the dexmedetomidine (Medetomidine) of the ketamine (Ketamine) of 75mg/kg and 0.5mg/kg is come anesthetized animal.After reaching enough anesthesia, pruned in the back, handles with betadin (betadine)/alcoholic solution of dilution, and use aseptic technique to cover the sterilization valance.Use No. 10 dissecting knife, pass skin at the back of each Mus and carry out the 8cm linear incision down to fascia.Edge of wound is cut to disconnect any remaining skin fiber by passivity, stays the open wound that diameter is approximately 4cm.Obtain hemostasis with institute's applied pressure, to avoid any infringement to skin edge.Use 4-0 acetylene continous suture skin suture edge then.After the operation, animal is accepted the Lepetan of 0.1-0.5mg/kg in peritoneal cavity.They are placed in individual cages, and arbitrarily accept food and water.
The EMF irradiation comprises two pulse radio-frequency waveforms.First is a standard clinical PRF signal, and it comprises 65 μ sec impulse trains of the 27.12MHz sine wave of 1 Gauss amplitude, and repeats with 600 impulse trains/sec.Second is the PRF signal that reconfigures according to embodiment of the present invention.For this signal, the impulse train persistent period is increased to 2000 μ sec, and amplitude and repetitive rate reduce to 0.2G and 5 impulse trains/sec respectively.Twice application every day PRF 30 minutes.
After debridement, measure tensile strength immediately.The wide skin bar of two 1cm perpendicular to from the cicatrix of each sample by crosscut, and be used to measure with kg/mm
2Tensile strength for unit.Described skin bar is cut the same area from every Mus, with the concordance of guaranteeing to measure.Then the skin bar is installed on the tonometer.With the described skin bar of 10mm/min load, and the maximum, force that produces before the record wound pulled apart.By to from two skin bars of same wound with mm
2/ kilogram is averaged for the maximum load of unit, is identified for the final tensile strength of comparison.
The result shows, with respect to 13.0 ± 3.5kg/mm of matched group
2, the average tensile strength of 65 μ sec1 Gauss PRF signals of irradiation group is 19.3 ± 4.3kg/mm
2(P＜.01), increased by 48%.On the contrary, with respect to 13.7 ± 4.1kg/mm of matched group
2, for the treatment group, using Power SNR model is 21.2 ± 5.6kg/mm according to the average tensile strength of 2000 μ sec, the 0.2 Gauss PRF signal of embodiment of the present invention configuration
2(P＜.01), increased by 54%.The result of these two signals does not have significant difference each other.
The non-thermal pulsed magnetic fields of noinvasive is to be used to cure the disunion fracture, to ease the pain and the edema and the therapy of curing the success of chronic wounds.Two radio frequency EMF devices that are used for this research are being different aspect impulse train persistent period, envelope, amplitude and the repetitive rate.The result that the result that second radio frequency produces and first radio frequency produce has shown the effectiveness according to EMF signal configures of the present invention much at one.
This result follows the pattern of observing in clinical and basic EMF research.Use correct dosimetry, that is, signal is detectable in the EMF sensitive pathway, the degree of the state decision effect of target.Therefore, normal on every side skeleton does not respond in significant mode on the physiology, even its is accepted and the identical EMF dosage of cell/tissue in the fracture site.Same phenomenon occurs for cells in culture, wherein reported the dependency of the EC of the state of cell cycle, tissue repair and ion/ligand.Therefore in fact EMF does not have effect in later stages of wound repair.By comparing, can infer that the wound of EMF treatment arrives wound repair latter stage than the fast about 1.5 times of ground of matched group with the known organism mechanics of this pattern healing curve.
At cellular level, EMF is shown as and improves TGF-β generation.The EMF type that is used for bone repair has significantly increased external endotheliocyte socket and propagation and fibroblast growth factor β-2.In addition, the anti-CD3 combination at EMF signal scalable lymphocyte receptor place shows that EMF can reduce inflammatory reaction.When the EMF effect appears in this skin wound pattern because reduced the time of inflammatory phase and with after-acceleration the collagen generation, realized the healing of quickening.The generation of having reported somatomedin is that Ca/CaM (calmodulin, CaM) is dependent, and has shown that the EMF signal promotes Ca
2+With combining of calmodulin, CaM.Organizing level, demonstrating electric field by the EMF induction of signal of being utilized and comprise the suitable frequency spectrum that will detect in conjunction with approach at Ca/CaM.Confirm that also the coupled EMF bone healing of Irritability signal can be increased in external osteoblastic proliferation by directly regulating Ca/CaM.
These results show that the EMF signal that embodiment of the present invention allow to be configured can produce with obviously lower power.PRF signal according to embodiment of the present invention configuration has quickened the wound repair in the mouse model in the low mode of the clinical EMF signal of power ratio, described clinical EMF signal accelerate wound repair, but need produce more than more power of two orders of magnitude.
Example 3
Originally studies confirm that: the effect according to the electromagnetic field of embodiment of the present invention configurations has been quickened the tendon reparation in the external model.
Average weight is that the young male Sprague-Dawley Mus of 350g is anaesthetized with the intraperitoneal injection of ketamine/dexmedetomidine mixture of 75mg/kg0.5mg/kg.Rupture of Achilles tendon also is repaired.Use sterile surgical technique, on right heel string, implement the 2cm center line and vertically cut, simultaneously by making right crus of diaphragm crooked and it is stretching.The blunt cutting is used for using dissecting knife at middle crosscut tendon then tendon and separate tissue on every side.Then use improved Kessler sewing to repair heel string at once with the 6-0 nylon suture.Plantaris muscle tendon is separated but is not repaired.Use the 5-0 Ethilon suture skin suture on the tendon of being repaired that is interrupted.Heel string is not fixed.After the operation, the animals received ketoprofen is with pain management.
At postoperative first day, all animals were randomized to either four treatment groups, 10 animals were arranged in every group.Randomization is followed parallel group protocol, and each animal is randomized to either a treatment group, has ten up to every group.Animal is retained in its specified group.Three matched groups of accepting an activity group and the identical treatment of two particular treatment phases of 30 minutes in during 3 week every day are arranged.The EMF that is used for this research is the pulse radio-frequency waveforms that comprises the repetitive burst of the 27.12MHz sine wave that is sent by the PMF power coil.Use two kinds of configurations.Distribute to group first kind of impulse train persistent period that comprises 65 μ sec of 1, repeat, and be 1 Gauss (G) in the amplitude of tendon target with the speed of 600 impulse trains/sec.Distribute to the impulse train persistent period that group second kind of PRF waveform of 2 comprises 2000 μ sec, repeat with the speed of 5 impulse trains/sec, and be 0.05G in the amplitude of tendon target, the impulse train of distributing to group 3 has the amplitude of 0.1G.There is not signal to be assigned to the control animal of group 4.
Use the monocycle coil to transmit signal, this monocycle coil is mounted to and makes standard plastic mouse cage of removing all metals parts as for wherein.This coil is positioned in the 3.5 inches places, top at the bottom of the cage, and parallel with it.With five animals of freely sauntering of each coil treatment.The EMF signal amplitude is examined.Signal amplitude in the Mus treatment cage in the normal range of Mus motion is ± 10% by unification.The concordance of jede Woche validation signal.Each has two cages matched group and movable group, and each cage has its EMF irradiation system of coding separately.Carry out the EMF treatment twice of 30 minute phase every day, up to sacrifice.Control animal is treated being equipped with in the identical cage of identical coil.
When the treatment phase in 3 week finishes, by cutting off at near-end ankle joint is broken away from from the belly of muscle of tendon and at far-end, obtain heel string, keep calcaneus to be connected with foot.Soft tissue that all are outside and sclerous tissues all remove from calcaneus-heel string assembly.After obtaining heel string, carry out the tensile strength test immediately.Than the heel string of vertical orientation, the tendon that is connected with the heel bone is fixed between two metal clips, goes up proximate dorsiflexion of foot so that keep the physiology.Draw back tendon with the constant speed of 0.45mm/sec then, up to fracture, and record peak value tensile strength.All analyzable tendons are in initial crosscut place fracture.Can obtain being used for analyzing from the tensile strength of totally 38 tendons.
After the tendon crosscut 3 week more every group average tensile strength, and analytical data.Tensile strength is calculated as the maximum fracture strength of kilogram/cross-sectional area (is unit with the square centimeter).Than the 80.6 ± 16.6kg/cm that organizes matched group in 4
2, the tendon with the treatment of 65 μ sec signals in group 1 has 99.4 ± 14.6kg/cm
2Average fracture strength.This expression is with respect to 24% increase at 21 days matched group, and this is not significant (p=.055) on statistics.80.6 ± 16.6kg/cm with respect to matched group
2, have obviously higher respectively for 129.4 ± 27.8kg/cm of 0.05G and 0.1G signal with the tendon from group 2 and group 3 of 2000 μ sec signals treatments
2With 136.4 ± 31.6kg/cm
2Average fracture strength.Than matched group, when the treatment in 3 week finished, the mean intensity of group 2 and group 3 improved 60% and 69% respectively.The increase of this intensity though statistically significant (p＜.001), however group 2 and the difference of organizing the average tensile strength between 3 are not significant (p=.541) on statistics.Group 1 (65 μ sec impulse train) and organize the though statistically significant (p＜.05) of the difference of the average tensile strength between 2 (the 2000 μ sec impulse trains).
Here the result of Chu Xianing shows, with respect to 21 days contrast tendon after crosscut, the noinvasive pulse electromagnetic field can produce Mus rupture of Achilles tendon intensity up to 69% increase.Be used for all signal accelerated tendon repair of this research, obtain maximum promotion but be to use according to the waveform that relates to the bonded Transduction Mechanism configuration of Ca2+.
Being similar to the mode of skeleton and wound repair, the tendon reparation of stndon sheath and synovial membrane sheath tendon is begun with inflammatory phase, this inflammatory phase is usually directed to the infiltration of inflammatory cell (as macrophage, neutrophil cell and T lymphocyte).Then be that angiogenesis, fibroblast proliferation and the collagen that is mainly the III type produce.At last, cell and collagen fibrils orient are to obtain maximum mechanical strength.These stages all appear in skeleton and the wound repair, and wherein EMF has confirmed effect, and are particularly interim at inflammation, angiogenesis and cell proliferation.
The EMF transduction pathway relates to the ions binding in comprising the adjusting approach of growth factor release.Much relevant with reparation with tissue growth somatomedin and production of cytokines depend on the Ca/CaM calmodulin, CaM.EMF is shown as and promotes Ca
2+With combining of calmodulin, CaM.Use the Ca/CaM transduction pathway to dispose 0.05 and 0.1G signal that this research is used.Purpose is at Ca
2+Produce enough electric field amplitude in the bonded frequency response, that is, and dosage.This will cause lower power, more efficient signal.This model validation, the impulse train persistent period of the amplitude place microsecond scope in the 0.05G scope is satisfied these purposes.Increase the 0.1G signal and do not limit induced current pathway, and reduce the dosage of expection with the small size of guaranteeing Mus tendon target.
EMF promotes bone repair by quickening to return to complete fracture strength.The contrast fracture finally reaches identical biomechanical end point, but sickness rate has increased.Biomechanical acceleration in the Mus linear full-thickness cutaneous wound is observed.It is about 60% that EMF has quickened wound repair in 21 days, obtains complete fracture strength than fast about 50% ground of untreated wound.
Described and be used to strengthen the equipment of pharmaceutical efficacy and the embodiment of method, noted, those skilled in the art can make amendment and change according to top instruction.Therefore, should be understood that in the scope and spirit of the present invention that the change carried out in disclosed particular of the present invention is being defined by the following claims.
Claims (35)
1. method that is used to strengthen wound repair, it comprises step:
At least one waveform that configuration has at least one waveform parameter;
Select the value of described at least one waveform parameter of described at least one waveform, in the target pathway structure, to maximize in signal to noise ratio and the PSNR power signal-to-noise ratio at least one;
Use described in the target pathway structure described at least one waveform of at least one in maximization described signal to noise ratio and the PSNR power signal-to-noise ratio, to produce electromagnetic signal; With
Described electromagnetic signal is coupled to described target pathway structure with healing acceleration mechanism.
2. the method for claim 1, wherein said healing mechanism comprise blood flow, neovascularization, vasodilation, mediator's bulk-growth factor and regulate in the angiogenesis at least one.
3. the method for claim 1, wherein said at least one waveform parameter comprises at least one parameter once: with multiple frequency component parameter between described at least one contoured configuration Cheng Zaiyue 0.01Hz and the about 100MHZ, follow the impulse train amplitude envelops parameter of the amplitude function that on mathematics, defines, the burst width parameter that changes at each place of repetition according to the width function that defines on the mathematics, the peak induction electric pulse field parameter that in described target pathway structure, between about 1 μ V/cm and about 100mV/cm, changes according to the function that defines on the mathematics, and the peak induction magnetoelectricity field parameter that in described target pathway structure, between about 1 μ T and about 0.1T, changes according to the function that defines on the mathematics.
4. method as claimed in claim 4, the amplitude function of wherein said definition comprise in 1/f frequency function, logarithmic function, chaotic function and the exponential function at least one.
5. the method for claim 1, wherein said target pathway structure comprise behind molecule, cell, tissue, organ, ion, part, chronic wounds, diabetic ulcer, venous stasis ulcers, pressure ulcer, non-healing wound, acute wounds, the surgical operation behind the wound and wound in the wound at least one.
6. the method for claim 1, it further comprises ion and part is combined with the adjusting molecule to promote the step of agglutination.
7. method as claimed in claim 6, the integrating step of wherein said ion and part comprise that regulating calcium combines with calmodulin, CaM.
8. method as claimed in claim 6, the integrating step of wherein said ion and part comprise the generation of regulating somatomedin in the target pathway structure.
9. method as claimed in claim 6, the integrating step of wherein said ion and part comprise regulates production of cytokines in the target pathway structure.
10. method as claimed in claim 6, the integrating step of wherein said ion and part comprises somatomedin and the cytokine that adjusting is relevant with tissue growth, reparation and maintenance.
11. the method for claim 1, it further comprises the step of application standard naturopathy method.
12. method as claimed in claim 11, wherein the standard physical Therapeutic Method comprises in heating, cooling, compressing, massage and the exercise at least one.
13. the method for claim 1, it further comprises the step of application standard therapeutic treatment.
14. method as claimed in claim 13, wherein the standard medical treatment comprises in tissue transplantation and the organ transplantation at least one.
15. an electromagnetic therapy equipment that is used to strengthen wound repair, it comprises:
Waveform generating apparatus, its generation have at least one waveform of at least one waveform parameter, and described at least one waveform parameter can be selected to and maximize in signal to noise ratio and the PSNR power signal-to-noise ratio at least one when repairing efficiency in the target pathway structure; With
Be connected to the Coupling device of described Waveform generating apparatus, it is used for from least one described at least one waveform generation electromagnetic signal described target pathway structure described signal to noise ratio of maximization and PSNR power signal-to-noise ratio, and be used for described electromagnetic signal is coupled to described target pathway structure, thereby quicken described target pathway structure repairing efficiency.
16. electromagnetic therapy equipment as claimed in claim 15, wherein said at least one waveform parameter comprises at least one following parameter: described at least one contoured configuration is become according to mathematical function multiple frequency component parameter between about 0.01Hz and about 100MHZ, follow the impulse train amplitude envelops parameter of the amplitude function that on mathematics, defines, the burst width parameter that changes at each place of repetition according to the width function that defines on the mathematics, the peak induction electric pulse field parameter that in described target pathway structure, between about 1 μ V/cm and about 100mV/cm, changes according to the function that defines on the mathematics, and the peak induction magnetoelectricity field parameter that in described target pathway structure, between about 1 μ T and about 0.1T, changes according to the function that defines on the mathematics.
17. electromagnetic therapy equipment as claimed in claim 16, the amplitude function of wherein said definition comprise in 1/f frequency function, logarithmic function, chaotic function and the exponential function at least one.
18. electromagnetic therapy equipment as claimed in claim 15, wherein said target pathway structure comprise behind molecule, cell, tissue, organ, ion, part, chronic wounds, diabetic ulcer, venous stasis ulcers, pressure ulcer, non-healing wound, acute wounds, the surgical operation behind the wound and wound in the wound at least one.
19. electromagnetic therapy equipment as claimed in claim 15, wherein said Coupling device comprise in active Coupling device, inductive coupled device, Capacitance Coupled equipment and the biochemistry Coupling device at least one.
20. electromagnetic therapy equipment as claimed in claim 15, wherein said Coupling device is coupled to described target pathway structure with described signal, to regulate combining of calcium and calmodulin, CaM.
21. electromagnetic therapy equipment as claimed in claim 15, wherein said Coupling device is coupled to described target pathway structure with described signal, to regulate in the generation of relevant somatomedin and cytokine at least one.
22. electromagnetic therapy equipment as claimed in claim 21, wherein said somatomedin comprise in fibroblast growth factor, platelet derived growth factor and the interleukin somatomedin at least one.
23. electromagnetic therapy equipment as claimed in claim 15, wherein said Coupling device is coupled to described target pathway structure with described signal, to regulate angiogenesis and neovascularization.
24. electromagnetic therapy equipment as claimed in claim 15, wherein said Coupling device is coupled to described target pathway structure with described signal, with the generation of mediator's somatomedin.
25. electromagnetic therapy equipment as claimed in claim 15, wherein said Coupling device is coupled to described target pathway structure with described signal, to increase cell and tissue activity.
26. electromagnetic therapy equipment as claimed in claim 15, wherein said Coupling device is coupled to described target pathway structure with described signal, to increase cell mass.
27. electromagnetic therapy equipment as claimed in claim 15, wherein said Waveform generating apparatus, connecting device and Coupling device are configured to light-duty and portative.
28. electromagnetic therapy equipment as claimed in claim 15, wherein said Waveform generating apparatus, connecting device and Coupling device merge in mattress, mattress cushion, bed and the positioning equipment at least one.
29. comprising, electromagnetic therapy equipment as claimed in claim 28, wherein said positioning equipment dissect in support, dissection wrappage and the medicated clothing at least one.
30. electromagnetic therapy equipment as claimed in claim 29, wherein said medicated clothing comprise in clothes, fashion accessory and the footgear at least one.
31. electromagnetic therapy equipment as claimed in claim 15, wherein said Waveform generating apparatus is programmable.
32. electromagnetic therapy equipment as claimed in claim 15, wherein said Waveform generating apparatus are transmitted at least one pulsed magnetic signal during preset time.
33. electromagnetic therapy equipment as claimed in claim 15, wherein said Waveform generating apparatus transmits at least one pulsed magnetic signal at time durations at random.
34. electromagnetic therapy equipment as claimed in claim 15, it further comprises the transfer device that is used for the standard physical Therapeutic Method.
35. electromagnetic therapy equipment as claimed in claim 34, wherein said standard physical Therapeutic Method comprise in heating, cooling, massage and the exercise at least one.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65896705P | 2005-03-07 | 2005-03-07 | |
| US60/658,967 | 2005-03-07 | ||
| US11/369,308 US20060212077A1 (en) | 2005-03-07 | 2006-03-06 | Electromagnetic treatment apparatus for augmenting wound repair and method for using same |
| US11/369,308 | 2006-03-06 | ||
| PCT/US2006/008000 WO2007044059A2 (en) | 2005-03-07 | 2006-03-07 | Electromagnetic treatment apparatus for augmenting wound repair and method for using same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101432041A true CN101432041A (en) | 2009-05-13 |
| CN101432041B CN101432041B (en) | 2012-04-25 |
Family
ID=40646992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2006800155097A Expired - Fee Related CN101432041B (en) | 2005-03-07 | 2006-03-07 | Electromagnetic treatment apparatus for augmenting wound repair and method for using same |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN101432041B (en) |
| ZA (1) | ZA200708478B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10870013B2 (en) | 2017-05-08 | 2020-12-22 | Aah Holdings Llc | Multi-coil electromagnetic apparatus |
| US11071876B2 (en) | 2018-12-03 | 2021-07-27 | Aah Holdings Llc | Apparatus and method for treatment of mental and behavioral conditions and disorders with electromagnetic fields |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2374568C (en) * | 1999-05-21 | 2011-11-22 | Exogen, Inc. | Apparatus and method for ultrasonically and electromagnetically treating tissue |
-
2006
- 2006-03-07 CN CN2006800155097A patent/CN101432041B/en not_active Expired - Fee Related
-
2007
- 2007-10-04 ZA ZA200708478A patent/ZA200708478B/en unknown
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10870013B2 (en) | 2017-05-08 | 2020-12-22 | Aah Holdings Llc | Multi-coil electromagnetic apparatus |
| US11338150B2 (en) | 2017-05-08 | 2022-05-24 | Aah Holdings, Llc | Multi-coil electromagnetic apparatus |
| US11071876B2 (en) | 2018-12-03 | 2021-07-27 | Aah Holdings Llc | Apparatus and method for treatment of mental and behavioral conditions and disorders with electromagnetic fields |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101432041B (en) | 2012-04-25 |
| ZA200708478B (en) | 2008-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7740574B2 (en) | Electromagnetic treatment induction apparatus and method for using same | |
| US7744524B2 (en) | Apparatus and method for electromagnetic treatment of plant, animal, and human tissue, organs, cells, and molecules | |
| US7758490B2 (en) | Integrated coil apparatus for therapeutically treating human and animal cells, tissues and organs with electromagnetic fields and method for using same | |
| EP1868591B1 (en) | Pharmacological, chemical, and topical agent enhancement apparatus | |
| KR20070119024A (en) | Electromagnetic treatment apparatus for augmenting wound repair and method for using same | |
| US20130218235A9 (en) | Excessive fibrous capsule formation and capsular contracture apparatus and method for using same | |
| EP1740107A1 (en) | Electromagnetic treatment apparatus and method | |
| CN101160152A (en) | Electromagnetic treatment induction apparatus and method for using same | |
| CN101432041B (en) | Electromagnetic treatment apparatus for augmenting wound repair and method for using same | |
| CN101505676A (en) | Pharmacological, chemical, and topical agent enhancement apparatus and method for using same | |
| WO2008051521A2 (en) | Excessive fibrous capsule formation and capsular contracture apparatus and method for using same | |
| KR20070015908A (en) | Electromagnetic treatment apparatus and method | |
| MX2008003378A (en) | Integrated coil apparatus and method for using same | |
| AU2005336126A1 (en) | Integrated coil apparatus and method for using same | |
| EP2077789A2 (en) | Excessive fibrous capsule formation and capsular contracture apparatus and method for using same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: IVIVI HEALTH SCIENCES, LLC Free format text: FORMER OWNER: MONTVILLE TECHNOLOGIES LTD. Effective date: 20120417 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C56 | Change in the name or address of the patentee |
Owner name: MONTVILLE TECHNOLOGIES LTD. Free format text: FORMER NAME: IVIVI TECHNOLOGIES INC. |
|
| CP01 | Change in the name or title of a patent holder |
Address after: New jersey, USA Patentee after: Meng Tver Technology Co.,Ltd. Address before: New jersey, USA Patentee before: IVIVI TECHNOLOGIES, Inc. |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20120417 Address after: California, USA Patentee after: IVIVI TECHNOLOGIES, Inc. Address before: New jersey, USA Patentee before: Meng Tver Technology Co.,Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120425 Termination date: 20210307 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |